A Screening Study Identified Decitabine as an Inhibitor of Equid Herpesvirus 4 That Enhances the Innate Antiviral Response
Viruses · 2024
DOI: 10.3390/v16050746 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Camille Normand und 9 weiteren Autor:innen. Beteiligte Einrichtung: LABÉO, 14280 Saint-Contest, France. Hauptthemen laut MEDLINE: Antiviral Agents, Decitabine, Herpesviridae Infections, Herpesvirus 4, Equid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: IFCE (Institut Français du Cheval et de l'Equitation), Fonds Eperon, Eperon HVE4 IRCP Fund.
Abstract (Originalsprache)
Equid herpesvirus 4 (EHV-4) is a common respiratory pathogen in horses. It sporadically induces abortion or neonatal death. Although its contribution in neurological disorders is not clearly demonstrated, there is a strong suspicion of its involvement. Despite preventive treatments using vaccines against EHV-1/EHV-4, the resurgence of alpha-EHV infection still constitutes an important threat to the horse industry. Yet very few studies have been conducted on the search for antiviral molecules against EHV-4. A screening of 42 antiviral compounds was performed in vitro on equine fibroblast cells infected with the EHV-4 405/76 reference strain (VR2230). The formation of cytopathic effects was monitored by real-time cell analysis (RTCA), and the viral load was quantified by quantitative PCR. Aciclovir, the most widely used antiviral against alpha-herpesviruses in vivo, does not appear to be effective against EHV-4 in vitro. Potential antiviral activities were confirmed for eight molecules (idoxuridine, vidarabine, pritelivir, cidofovir, valganciclovir, ganciclovir, aphidicolin, and decitabine). Decitabine demonstrates the highest efficacy against EHV-4 in vitro. Transcriptomic analysis revealed the up-regulation of various genes implicated in interferon (IFN) response, suggesting that decitabine triggers the immune antiviral pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- LABÉO, 14280 Saint-Contest, France.
- Normandie Université, UNICAEN BIOTARGEN, 14280 Saint-Contest, France.
- Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
- Louisiana Animal Disease Diagnostic Laboratory, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
- Normandie Université, UNICAEN, ImpedanCELL, 14280 Saint-Contest, France.
- Cytokines and Adaptive Immunity Lab, Sainte-Justine University Hospital and Research Center, University of Montréal, Montreal, QC H3T 1C5, Canada.
ORCID-Profile: Camille Normand, Côme J Thieulent, Catherine Senamaud-Beaufort, Corinne Blugeon, Pierre-Olivier Vidalain, Stéphane Pronost, Erika S Hue
Förderung
- IFCE (Institut Français du Cheval et de l'Equitation)
- Fonds Eperon
- Eperon HVE4 IRCP Fund
- Conseil Régional de Normandie, European Union
Zitieren
APA
Normand, C., Thieulent, C. J., Fortier, C., Sutton, G., Senamaud-Beaufort, C., Jourdren, L., Blugeon, C., Vidalain, P. O., Pronost, S., & Hue, E. S. (2024). A Screening Study Identified Decitabine as an Inhibitor of Equid Herpesvirus 4 That Enhances the Innate Antiviral Response. Viruses. https://doi.org/10.3390/v16050746
Vancouver
Normand C, Thieulent CJ, Fortier C, Sutton G, Senamaud-Beaufort C, Jourdren L, et al. A Screening Study Identified Decitabine as an Inhibitor of Equid Herpesvirus 4 That Enhances the Innate Antiviral Response. Viruses. 2024. doi:10.3390/v16050746
BibTeX
@article{Normand2024,
author = {Normand, Camille and Thieulent, Côme J and Fortier, Christine and Sutton, Gabrielle and Senamaud-Beaufort, Catherine and Jourdren, Laurent and Blugeon, Corinne and Vidalain, Pierre-Olivier and Pronost, Stéphane and Hue, Erika S},
title = {A Screening Study Identified Decitabine as an Inhibitor of Equid Herpesvirus 4 That Enhances the Innate Antiviral Response},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16050746}
}
EUVIMED